End of Life clinical trials at UCSF
6 in progress, 4 open to eligible people
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
open to eligible people ages 21 years and up
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
San Francisco, California and other locations
Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer
open to eligible people ages 18 years and up
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.
San Francisco, California and other locations
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer
open to eligible people ages 18 years and up
This trial investigates whether a joint and integrative approach to cancer care using palliative care and psycho-oncology is possible, and if it's beneficial to patients with cancer that has spread to other places on the body (advanced). The information gained from this study may help patients to learn about the medicinal and non-medicinal strategies to cope with their symptoms and side effects of their diagnosis and treatment while receiving peer support, in addition to standard individualized medical care.
San Francisco, California
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
open to eligible people ages 18-120
This is a comparative effectiveness study of two pragmatic models aiming to introduce palliative care for end stage liver disease patients. The 2 comparators are: Model 1: Consultative Palliative Care (i.e. direct access to Palliative Care provider), Model 2: Trained Hepatologist- led PC intervention (i.e. a hepatologist will receive formal training to deliver Palliative Care services) Primary Outcome: The change in quality of life from baseline to 3 months post enrollment as assessed by FACT-Hep (Functional Assessment of Cancer Therapy- Hepatobiliary). 14 Clinical Centers across US are recruited to participate in this study.
Fresno, California and other locations
Improving Palliative Care Access Through Technology
Sorry, currently not accepting new patients, but might later
This project will focus on developing, optimizing and pilot-testing a multi-component Improving Access Through Technology (ImPAcTT) intervention that leverages existing telehealth technologies to provide staff education; family outreach, engagement and support; care coordination; and resident symptom management and facilitation of goals-of-care discussion.
San Francisco, California and other locations
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Sorry, not yet accepting patients
This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).
Our lead scientists for End of Life research studies include Stephanie Cheng, MD Rebecca Sudore, MD.
Last updated: